Monthly Archives: December 2011

Poultry & Antibiotics

No Comments
December 5  |  antibiotics, Case Studies, food safety, Latest News, News, Poultry, Reports, Tests  |   Admin

B.C. poultry industry warned to halt use of antibiotic

Level of drug-resistant bacteria spikes in grocery-store chicken

The Public Health Agency of Canada is warning B.C. poultry farmers and veterinarians to stop using a bovine antibiotic on chickens.

The agency believes the practice is behind a significant spike in drug-resistant Campylobacter bacteria found in chicken tested from grocery stores.

The bacteria are resistant to an antibiotic commonly used to treat respiratory infections in human beings and cattle.

The dramatic spike in the bacteria was first noticed during routine sampling of B.C. chicken from grocery stores in 2009. Levels have remained stubbornly above normal in this province ever since.

Positive tests for the resistant strain of Campylobacter in retail chicken have ranged as high as 40 per cent in B.C. and 28 per cent in Saskatchewan compared with an average of less than four per cent in the other provinces monitored by the Canadian Integrated Program for Antimicrobial Resistance Surveillance. Campylobacter is the most common food-borne pathogen in Canada; it is usually associated with substandard food handling and consumption of undercooked chicken.

The rate of human Campylobacter poisoning in B.C. has been about 30 per cent above the national average during the past 10 years, according to the BC Centre for Disease Control. People who contract drug-resistant Campylobacter from contaminated food can become more severely ill with diarrhea, fever and abdominal pain than those who get typical Campylobacter, the bulletin stated.

Thorough cooking kills the bacterium.

A total of 1,750 cases were reported in B.C. during 2009, but it is not known whether any of those cases were antimicrobial resistant.

CIPARS is comparing Campylobacter from human cases in B.C. and Saskatchewan with the bacteria from retail poultry to determine whether the same pathogen is infecting people who eat poultry.

A recent bulletin to be released to the web this week by CIPARS attributes the increase in drug-resistant Campylobacter in B.C. chicken to use of the antimicrobial drug fluoroquinolone. The agency says veterinary fluoroquinolones labelled for cattle are being used “off-label” to prevent salmonella in chicken in breeder flocks.

Antibiotics are sometimes used in crowded, large-scale chicken rearing to prevent fast-spreading illnesses from infecting entire flocks.

Health Canada requires fluoroqui-nolone-based veterinary drugs for cattle to carry a warning not to use them in any other species. Public health authorities want to curb the use of flu-oroquinolone in chicken because the risk of spreading drug-resistance to those medications could render them ineffective in human medicine.

It is not unusual for veterinarians to use antibiotics labelled for one species on another animal species, but steps are being taken within the poultry industry to stamp out the practice.

However, veterinarians are approved to prescribe veterinary and human drugs according to the recommendations of Health Canada or off-label at their discretion, according to John Brocklebank, deputy registrar of the College of Veterinarians of B.C.

B.C.’s poultry farming association has issued a warning written by agriculture ministry veterinarian Bill Cox in July instructing producers not to use prescription drugs on their flocks except under veterinary supervision and not to use any drug without a veterinary diagnosis.

Chicken Farmers of Canada executive director Mike Dungate said anti-microbial resistance is one of the industry’s “critical” concerns.

Chicken producers are required to report all medications given to their flocks to the Canadian Food Inspection Agency before they are sent for processing. That information is verified by government veterinarians, according to CFC safety program manager Steve Leech.

The CFC and CIPARS are developing a national on-farm surveillance program designed to record antimicrobial use and pinpoint the sources of antimicrobial-resistant pathogens.

The CFC hopes the program will explain B.C.’s persistently higher incidence of antimicrobial resistant Campylobacter and correlate that with on-farm practices,” Leech said. The CFC maintains there is no conclusive use of veterinary drugs on farms with the drug-resistant bacteria detected in samples taken from chicken in B.C. grocery stores.

But drug-resistant pathogens in food are known to pass to humans, according to the Public Health Agency of Canada. A spike in the incidence of Salmonella Heidelberg found in chicken tested from grocery stores in Quebec in 2003 and 2004 was accompanied by a rise in human cases of the same drug-resistant Salmonella in humans.

Although CIPARS doesn’t have the authority to collect data about veterinary antibiotic use at the provincial level, researchers learned from industry sources that 70 per cent of hatchery operators in Quebec were using the antibiotic ceftiofur on healthy birds to prevent E. coli infections, according to Rebecca Irwin, director of the surveillance division of the Laboratory for Foodborne and Zoonoses at the Public Health Agency of Canada.

The incidence of the drug-resistant strain subsided in both humans and chickens after Quebec hatchery farmers voluntarily stopped using the anti-biotic, she said.

rshore@vancouversun.com     © Copyright (c) The Vancouver Sun

Hydrogen Peroxide UofW study

No Comments
December 5  |  Immune System, Latest News, News, Research  |   Admin

Hydrogen Peroxide Provides Clues to Immunity, Wound Healing, Tumor Biology

Madison, Wisconsin – Hydrogen peroxide isn’t just that bottled colorless liquid in the back of the medicine cabinet that’s used occasionally for cleaning scraped knees and cut fingers.It’s also a natural chemical in the body that rallies at wound sites, jump-starting immune cells into a viagra of events.

 

A burst of hydrogen peroxide causes neutrophils, the immune system’s first responders, to rush to the wound to fight microorganisms, remove damaged tissue and then start the inflammation process.

 

University of Wisconsin-Madison researchers now have discovered the molecular sensor that detects wound-induced hydrogen peroxide and orchestrates the marshalling of neutrophils and other immune cells, or leukocytes, including those that affect tumors.

 

Published in the Nov. 20, 2011, advanced online version of the journal Nature, the findings have broad implications for cancer biology as well as wound healing and the way the body fights infections.

 

“Our findings suggest that in the future we might be able to manipulate the new pathway we’ve found to make immune cells go where we want them to,” says lead author Dr. Anna Huttenlocher of the UW School of Medicine and Public Health (SMPH).

 

A tumor is a type of unhealed wound, says Huttenlocher. Tumors and wounds both generate high levels of hydrogen peroxide, and immune cells responsible for inflammation seek out wounds as well as tumors.
But inflammatory cells can often be detrimental. The cells can contribute to a tumor’s ability to grow and invade other tissue, and they can cause chronic inflammation at wound sites.

 

“We now speculate that the recruitment of immune cells for wound healing and tumor growth involves a different molecular pathway than recruitment of immune cells for fighting infections,” says Huttenlocher, a professor of pediatrics and of medical microbiology and immunology in the School of Medicine and Public Health.

 

The researchers used transparent zebrafish larvae in a model they have developed to study immunity to watch neutrophils move to wounds in the tails of fish larvae.

 

They found that hydrogen peroxide modified a protein called Lyn, and that the modification let neutrophils go to wound sites along a specific cellular pathway.

 

“If we blocked Lyn, it’s possible cells could still get to infection sites, where they could be helpful, but not to wounds or tumors, where they could be harmful,” Huttenlocher says.

 

Sa Kan Yoo was first author on the paper; Taylor W. Starnes and Qing Deng were co-authors.

 

The experiments showed clearly that Lyn activation was dependent on hydrogen peroxide after tissue injury, and that blocking Lyn reduced the recruitment of neutrophils to wounds. Lyn is expressed specifically in leukocytes as a sensor for hydrogen peroxide.

 

Lyn is also a member of a powerful class of proteins known as Src family kinases (SFKs). Many of these kinases have been identified as cellular oncogenes, or precursors to cancer.

 

“Lyn bridges SFKs and the new pathway we have identified, broadly linking wound healing and immunity to changes in cell behavior in cancer,” says Huttenlocher. “That connection may help move us forward with a better understanding of wound healing and cancer.”

 

Lyn’s connection to hydrogen peroxide should also elevate the chemical’s status from the back of the medicine cabinet to a position of much greater interest.

Date Published: 11/21/2011

 

  1. We welcome any feedback, questions or comments